Future of T1D Research

JDRF is creating a future without type 1 diabetes (T1D) by funding and advocating for breakthrough scientific research. One of our strategies is to help promising scientists establish careers in the field of T1D research. The investigators featured here form the newest group to receive early-career funding from JDRF. Meet the future of T1D research.

Career Development Awards

  • Andrew Sutherland

    Type 17 immunity in T1D

    St Vincent's Institute of Medical Research

  • Everett Meyer

    Developing chimeric antigen receptor T-regulatory cells for islet allograft tolerance

    Stanford University

    Link to blog post

  • Jeffrey Millman

    Improved generation of stem cell-derived beta cells

    Washington University

Early Career Patient-Oriented Diabetes Research Awards

  • Brigitte Frohnert

    Gene-lipidome interaction in late-onset islet autoimmunity

    University of Colorado

Advanced Postdoctoral Fellowships

  • Candace Reno

    Preventing severe hypoglycemia-induced cardiac arrhythmias

    University of Utah

  • Chiara Fabris

    CGM-based insulin sensitivity estimation to improve insulin dosing in T1D

    The University of Virginia

  • Eleni Beli

    Novel insights on the link between diabetic retinopathy and the splenic clock

    Indiana University

  • Erine Budi

    Integration of increased TGF-beta signaling in the cellular response to insulin or high glucose

    University of California, San Francisco

  • Manoj Gupta

    Modeling T1D and its associated complications using human induced pluripotent stem cells

    Joslin Diabetes Center

  • Nina Funa

    Identification of signaling pathways controlling expansion of human pancreatic progenitor cells

    The Danish Stem Cell Center, The University of Copenhagen

  • Xuewei Wang

    Nitric oxide-releasing cannula integrated with glucose electrode for long-term single-port glycemic control

    The University of Michigan

Postdoctoral Fellowships

  • Devy Deliyanti

    Boosting the immune system to treat diabetic retinopathy

    Monash University

  • Diao Chen

    Development of glucose-responsive insulin derivatives

    University of Utah

  • Jenny Aurielle Babon

    Autoreactive CD8 T cell infiltrates from the islets of human subjects with T1D

    University of Massachusetts Medical School

  • Jessica Weaver

    Localized immunomodulation to induce tolerance in an extrahepatic encapsulated islet graft

    Georgia Institute of Technology

    Link to blog post

  • Kacey Prentice

    Targeting lipid chaperone adipocyte protein 2 (aP2) for the prevention of T1D

    Harvard College

  • Kim-Vy Nguyen-Ngoc

    Establishing vascularized human pancreatic islets from hESCs

    University of California, San Diego

  • Piotr Kowalski

    Engineering mRNA nanocarriers to rescue pancreatic beta cells in T1D

    Massachusetts Institute of Technology

    Link to blog post

  • Purushothaman Kuppan

    Novel functionalized retrievable scaffolds for islet transplantation

    The University of Alberta

  • Robert Bone

    ER calcium dyshomeostasis in the pathogenesis of T1D

    Indiana University

  • Satoru Akazawa

    Defining a new role for granzyme A in maintaining immune tolerance

    St Vincent's Institute of Medical Research

  • Saurabh Vig

    Role of surface-expressed glucose-regulated protein 78 in beta cells and their cross-talk with the immune system

    KU Leuven

  • Vishwendra Patel

    The role of perifornical hypothalamic orexin-glucose inhibited neurons in hypoglycemia awareness

    Rutgers, The State University of New Jersey

  • Wentong Long

    Bioengineering adipocytes for the regulated release of bioactive insulin

    The University of Alberta

  • Xiaochun Xiong

    Development of an ultrafast-acting insulin

    University of Utah

  • Yen-Shan Chen

    Design of a glucose-responsive insulin based on a conformational switch

    Case Western Reserve University

    Link to blog post

  • Yi-Chun Chen

    Alternatively processed forms of islet amyloid polypeptide as predictive biomarkers for T1D

    The University of British Columbia

  • Yunxian Liu

    Systematic identification and validation of causal variants and genes targets associated with T1D

    The University of Virginia

JDRF-ISPAD Fellowships

  • Beata Malachowska

    Role of lysophosphatidic acid, and elevated serum biomarker, in pathogenesis of HNF1B mediated MODY

    Medical University of Lodz, Lodz, Poland

    Link to blog post

  • Gianluca Tornese

    Role of "taste" in metabolic regulation in T1D and mapping of mechanistically involved genes and pathways

    Institute for Maternal and Child Health “Burlo Garofolo”, Trieste, Italy

    Link to blog post

  • Marie Beatrice Saade

    Efficacy of two carbohydrate intake strategies with similar carbohydrate content but different timing to reduce exercise-induced hypoglycemia in children with type 1 diabetes

    Institut de recherches cliniques de Montréal, Montreal, Canada

    Link to blog post

  • Petter Bjornstadt

    Diabetic Kidney Alarm study: Tubulopathy in new onset diabetic ketoacidosis

    University of Colorado School of Medicine, Colorado, US

    Link to blog post

  • Arun Kumar Singh

    Allan Drash Clinical Fellowship

    B. P. Koirala Institute of Health Sciences, Dharan, Nepal

    Link to blog post

  • Joshua Ngwang Menang

    Allan Drash Clinical Fellowship

    Cameroon Laboratory & Medicine Foundation Health Center, Tiko, Cameroon

    Link to blog post

  • Mohammad Hosny

    Allan Drash Clinical Fellowship

    Mansoura University Children’s Hospital, Mansoura, Egypt

    Link to blog post

  • Wafaa Laymoun

    Allan Drash Clinical Fellowship

    Mansoura University Children’s Hospital, Mansoura, Egypt

    Link to blog post

  • Naina Bhat

    Allan Drash Clinical Fellowship

    St John’s Medical College and Hospital, Bangalore, India

    Link to blog post

  • Feny Patel

    Allan Drash Clinical Fellowship

    Clinic Ahmedabad, Gujarat, India

    Link to blog post

Get Involved

By donating your time or dollars, you are funding promising new scientists who share our mission of ending T1D.